KNW: Know Labs Inc Price to Sales

Symbol and logo of brand Know Labs Inc (KNW)

Know Labs, Inc. (KNW) develops innovative RF sensors for non-invasive glucose monitoring using proprietary Bio-RFID technologies. The estimated P/S ratio reflects the company's current market valuation, where 5978.50 describes the current status of the metric. An environmental development vector minimizes plastic waste, while the pristine condition of production facilities and equipment calibration ensure the stable output of biosensors.

KNW (Know Labs) P/S Multiple history from 04/28/2023 to 05/20/2023

Analytical breakdowns for Know Labs Corp (KNW)

- market price and analyst price targets:
- market capitalization information:
Fundamental company analysis:knowlabs.co KNW
Original product of Know Labs Corp

The development of non-invasive glucose monitoring systems for diabetics determines the future cash flows of Know Labs, Inc. (KNW) via insurance payouts. The ratio of market capitalization to sales, represented by the company's average P/S, measures the current business value relative to revenue, where an inflated multiple signals a risk of asset impairment when compared to historical trends.

Who Know Labs, Inc. competes with

Market Cap to Revenue dexcom.com DXCM|P/S Multiple PEN (Penumbra)|Novanta Inc (NOVT) - Price to Sales|Haemonetics Corp. - P/S Multiple|INSP (Inspire Medical Systems Inc) - Market Cap to Revenue Ratio|PRCT: P/S Multiple|CNMD - Price-to-Revenue Coefficient|PLSE (Pulse Biosciences) - P/S Multiple|Market Cap to Revenue InMode Ltd (INMD)|P/S Multiple PMI|P/S Multiple Surmodics Inc. (SRDX)|Price-to-Revenue Ratio Senseonics Holdings SENS|neuropace.com - Price-to-Revenue Ratio|TCMD: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio SNWV (SANUWAVE Health)|OM: P/S Multiple|Price to Sales Electromed (ELMD)|Price-to-Revenue Ratio LENSAR, Inc.|RCEL - Price-to-Revenue Multiple|Market Cap to Revenue PROF (Profound Medical Corp.)|P/S Multiple bairdmed.com (BDMD)|P/S Multiple EDAP (EDAP TMS)|Price-to-Revenue Coefficient Apyx Medical Corp (APYX)|ICCM - Price-to-Revenue Ratio|Price-to-Sales Ratio LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Market Cap to Revenue CytoSorbents Corporation|SRTS (Sensus Healthcare Corp) - P/S Multiple|Price to Sales Zynex Corp ZYXI|Price-to-Revenue Ratio electroCore, Inc. (ECOR)|vicarioussurgical.com - Market Cap to Revenue Ratio|Inspira Technologies - Market Cap to Revenue|Market Cap to Sales Volume ICU (SeaStar Medical Holding Corporation)|IRIX - Price-to-Revenue Ratio|INBS - P/S Multiple|beyondair.net (XAIR) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio PFSA|Price-to-Revenue Ratio STRATA Skin Sciences Inc.|Price to Sales glucotrack.com GCTK|Market Cap to Revenue NAOV (NanoVibronix)|Market Cap to Revenue Venus Concept Corporation VERO|Nuwellis, Inc. - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio AEMD|ASXC - Price-to-Revenue Ratio|AVGR: Price-to-Revenue Ratio|BSGM: P/S Multiple|Cutera Inc (CUTR) - P/S Multiple|NARI (Inari Medical, Inc.) - P/S Multiple|Price-to-Revenue Ratio NVRO|Price-to-Revenue Ratio ReShape Lifesciences (RSLS)|Price-to-Revenue Coefficient Silk Road Medical, Inc.